FRANKFURT, March 22 — The Covid-19 vaccine developed by Oxford University and AstraZeneca was 79 per cent effective in preventing symptomatic illness a large trial in the United States, Chile and Peru, the company said on Monday, paving the way for it to apply for US approval. The vaccine was 100...

https://www.malaymail.com/news/world/2021/03/22/astrazeneca-vaccine-79pc-effective-in-us-trial-panel-finds-no-higher-risk-o/1960000